[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 63, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.46, "open": 8.45, "dayLow": 8.44, "dayHigh": 8.85, "regularMarketPreviousClose": 8.46, "regularMarketOpen": 8.45, "regularMarketDayLow": 8.44, "regularMarketDayHigh": 8.85, "payoutRatio": 0.0, "beta": 1.724, "forwardPE": -6.5827603, "volume": 8498614, "regularMarketVolume": 8498614, "averageVolume": 3228834, "averageVolume10days": 3037090, "averageDailyVolume10Day": 3037090, "bid": 6.61, "ask": 8.68, "bidSize": 2, "askSize": 1, "marketCap": 1147448832, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 11.2, "allTimeHigh": 18.84, "allTimeLow": 1.03, "priceToSalesTrailing12Months": 17.25461, "fiftyDayAverage": 8.763, "twoHundredDayAverage": 5.53465, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1028692864, "profitMargins": -1.51148, "floatShares": 80160147, "sharesOutstanding": 134677094, "sharesShort": 33248529, "sharesShortPriorMonth": 29388713, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.2469, "heldPercentInsiders": 0.049450003, "heldPercentInstitutions": 0.97409, "shortRatio": 10.46, "shortPercentOfFloat": 0.2863, "impliedSharesOutstanding": 134677094, "bookValue": 1.434, "priceToBook": 5.941423, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -100515000, "trailingEps": -0.91, "forwardEps": -1.29429, "enterpriseToRevenue": 15.469, "enterpriseToEbitda": -9.533, "52WeekChange": 1.6377709, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 8.52, "targetHighPrice": 15.0, "targetLowPrice": 11.0, "targetMeanPrice": 13.25, "targetMedianPrice": 13.5, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 152811008, "totalCashPerShare": 1.135, "ebitda": -107913000, "totalDebt": 34763000, "quickRatio": 8.285, "currentRatio": 8.88, "totalRevenue": 66501000, "debtToEquity": 21.723, "revenuePerShare": 0.602, "returnOnAssets": -0.24517, "returnOnEquity": -0.51652, "grossProfits": -67500000, "freeCashflow": -62384376, "operatingCashflow": -145815008, "revenueGrowth": 3.636, "grossMargins": -1.01502, "ebitdaMargins": -1.6227299, "operatingMargins": 0.26150998, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "priceEpsCurrentYear": -9.479834, "fiftyDayAverageChange": -0.24299908, "fiftyDayAverageChangePercent": -0.027730126, "twoHundredDayAverageChange": 2.9853506, "twoHundredDayAverageChangePercent": 0.5393929, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "fiftyTwoWeekLowChange": 7.4900007, "fiftyTwoWeekLowChangePercent": 7.2718453, "fiftyTwoWeekRange": "1.03 - 11.2", "fiftyTwoWeekHighChange": -2.6799994, "fiftyTwoWeekHighChangePercent": -0.23928566, "fiftyTwoWeekChangePercent": 163.77708, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.91, "epsForward": -1.29429, "epsCurrentYear": -0.89875, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 0.030513098, "postMarketPrice": 8.5226, "postMarketChange": 0.0025997162, "regularMarketChange": 0.0600004, "regularMarketDayRange": "8.44 - 8.85", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3228834, "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.709225, "regularMarketPrice": 8.52, "corporateActions": [], "postMarketTime": 1766182471, "regularMarketTime": 1766178001, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]